Linden Capital Partners (Linden), has completed its acquisition of Aspirion, a specialist in technology-enabled healthcare revenue cycle management (RCM), from Aquiline Capital Partners.
The Chicago-based private equity firm, which focuses exclusively on the healthcare industry, is joined by Varsity Healthcare Partners (VHP), a healthcare services private equity firm with RCM investing experience through its portfolio company Ventra Health, as a minority shareholder.
Aspirion is a provider of RCM services for complex claims and revenue integrity, offering a broad array of technology-driven solutions for the most specialised revenue cycle challenges faced by hospital systems and healthcare providers.
To support Aspirion’s growth plan, Linden has assembled a Board of Directors that brings considerable expertise in software, data, and AI/ML solutions, along with deep RCM industry knowledge. The new Board will work closely with the Aspirion team to help realise Linden and management’s shared vision to drive a step change improvement in RCM solutions, providing better outcomes for healthcare providers, and ultimately the patients they serve.
The board is composed of Miki Kapoor, operating partner at Linden and founding CEO of Verana Health, Rand Ballard, chief customer officer at Vizient and previously chief operating officer, chief customer officer and in the office of the chief executive officer at MedAssets, Nick Giannasi, chief product officer at Ciox and former chief artificial intelligence officer at Change Healthcare, Jason Erdell, Richard Thomas, Linden Partner Kam Shah, Linden Vice President Arsi Sefaj, and VHP managing partner David Alpern.
